![]() |
Page History
...
Owner(s) | Action Item | Due Date | Status | ||||
---|---|---|---|---|---|---|---|
Group Members | Find any disease elements that are not already represented | Ongoing | Ongoing | ||||
Working Group | Review the new CDE Spreadsheet for the next meeting (ensure it covers the correct definitions and terms are correct) | Jun 26 | Open | ||||
Mary Cooper / Susan Pannoni | Look into CDISC to see their responses and match what is in our spreadsheet | Jul 10 | Mary Cooper | Look in the CDE browser and see if the terms are used by CDISC | Jun 26 | Open | |
Susan Pannoni | Add column for comments/thoughts to new CDE tab(s) to note reasons for not using elements | Jun 26Jul 10 | Open | ||||
Liz Ness | Pull up example for when immunological response could be used | Jun 26Jul 10 | Open | ||||
Susan Pannoni | Research immunological response - FDA considers this under biologic agents | Jun 26Jul 10 | Open | ||||
Anne Tompkins & Liz Ness | Tumor pathologic response - Uncover form and possible value list. Lymphoma SME? | Jun 26 | Open | Cathy Rankin | Forward pathologic response to Susan Pannoni | Jun 26Jul 10 | Open |
Diane Paul | Send some examples of QOL performance status | Jun 26 | Open | ||||
Neesha Desai | Change the July 3rd meeting to Monday July 1st | Jun 26 | Open | ||||
Jul 10 | In-Process | ||||||
Working Group | Review the new CDE Spreadsheet for the next meeting (ensure it covers the correct definitions and terms are correct) | Jul 15 | Susan Pannoni | Touch base with Dianne on how to handle the Response Method CDE | Jun 27 | Open |
Working Group Documents
...